166 results about "Contraindication" patented technology

This invention relates to an interactive medication container or console that hold or otherwise organizes one or more medication vials or containers. Each vial has a memory strip containing medication and prescription information. Each vial can also include a reminder unit that is attached to and portable with the individual vials. The console or reminder unit reads the information strip of the vial and communicates this information to or interacts with a patient to remind them to take the medication. The medication container or reminder unit also gathers or tracks information such as consumption time, quantity remaining, patient feedback, and contraindication information. The medication container or reminder unit interacts with the patient by displaying questions or receiving and recording input from the patient before, during or after a dose of medication is taken. The patient input can be used to modify the dosing regimen for future doses of medication. The medication container reorders medication when the quantity remaining reaches a threshold level. Contraindication information in the memory strip is downloaded to a personal home computer or a hospital or nursing home computer.

This invention relates to an interactive medication container or console that hold or otherwise organizes one or more medication vials or containers. Each vial has a memory strip containing medication and prescription information. Each vial can also include a reminder unit that is attached to and portable with the individual vials. The console or reminder unit reads the information strip of the vial and communicates this information to or interacts with a patient to remind them to take the medication. The medication container or reminder unit also gathers or tracks information such as consumption time, quantity remaining, patient feedback, and contraindication information. The medication container or reminder unit interacts with the patient by displaying questions or receiving and recording input from the patient before, during or after a dose of medication is taken. The patient input can be used to modify the dosing regimen for future doses of medication. The medication container reorders medication when the quantity remaining reaches a threshold level. Contraindication information in the memory strip is downloaded to a personal home computer or a hospital or nursing home computer.

A medical database and associated methods are especially suited for compiling information in a medical malpractice situation. A general medical database is provided and specific medical information corresponding to a given situation is entered. Entry of the information automatically cross-references some terms of the entered data to definitions in the general medical database. Terms are readily looked up when reviewing specific medical information and definitions are easily inserted where desired. A drug reference display provides two-way lookup from drugs to their side effects (or contraindications or interactions) and back. Significant information from an entered medical chronology is easily copied to a significant information section when a reviewer finds the information important.

Intelligent refrigerator system for storing pharmaceutical product containers, such as vials, ampules, syringes, bottles, medication tubes, blister packs and cartons, at the point of dispensing. Embodiments of the invention use product identification technology, such as radio-frequency identification (RFID) tags and readers, to uniquely identify containers as they are added to or removed from the cold storage compartment of the refrigerator, and automatically retrieve from a local or remote database a variety of details associated with the containers and their contents, such as manufacturing data, expiration dates, time out of refrigeration, inventory levels, safety information, usage statistics, known contraindications and warnings, etc. If the details indicate that there is a problem with a particular pharmaceutical (e.g., that it is counterfeit, expired, suspect, spoiled, recalled or almost depleted), then a message or warning is automatically delivered to a human operator via an attached output device, such as a display screen, speaker or printer. Embodiments of the invention may also be configured to monitor and report temperature faults, power failures and other anomalies associated with the refrigerator or cold storage compartment.

Intelligent refrigerator system for storing pharmaceutical product containers, such as vials, ampules, syringes, bottles, medication tubes, blister packs and cartons, at the point of dispensing. Embodiments of the invention use product identification technology, such as radio-frequency identification (RFID) tags and readers, to uniquely identify containers as they are added to or removed from the cold storage compartment of the refrigerator, and automatically retrieve from a local or remote database a variety of details associated with the containers and their contents, such as manufacturing data, expiration dates, time out of refrigeration, inventory levels, safety information, usage statistics, known contraindications and warnings, etc. If the details indicate that there is a problem with a particular pharmaceutical (e.g., that it is counterfeit, expired, suspect, spoiled, recalled or almost depleted), then a message or warning is automatically delivered to a human operator via an attached output device, such as a display screen, speaker or printer. Embodiments of the invention may also be configured to monitor and report temperature faults, power failures and other anomalies associated with the refrigerator or cold storage compartment.

A medical diagnosis system based on big data comprises a diagnosis and treatment scheme database.Information of the diagnosis and treatment scheme database and information of a patient inspection result are combined and transmitted to a prescription generation module.The prescription generation module transmits the information to a patient drug-use module.The patient drug-use module transmits the information to an information feedback module.The information feedback module transmits the information to the diagnosis and treatment scheme database.The patient inspection result can also be transmitted to a patient information base.The diagnosis and treatment scheme database and the patient information base transmit the information to a hospital information system.The big data technology is utilized for building the diagnosis and treatment scheme data, the prescription generation module can synthesize all inspection result data and automatically give out prescription or treatment schemes, drug effect conflicts or drug-use contraindication among drugs can be avoided, curative effect feedback information of a patient is included, communications between a doctor and the patient can be increased, more treatment reference information can be given to the doctor, the patient can go to the doctor conveniently, and medical accidents can be reduced.

A computer-implemented apparatus or method, or a software product, for generating a composite quantitative comparison of drug products based on multiple attributes of them. A set of name-attribute similarity scores are generated based on similarities among the names of selected target and reference drugs. A set of product-attribute similarity scores are generated based on similarities among product attributes of the selected target and reference drugs. A target drug confusability score is generated based on the confusability of the target drug as compared to a population of other drugs. The composite quantitative comparison is generated based on a composite of the name-attribute and product-attribute similarity scores, and the target confusability score. A set of one or more severity of confusion scores may also be included in the composite quantitative comparison. These scores are based on one or more indicators of the severity of the consequences to a patient of confusing the target and reference drugs so that, for example, the wrong drug is administered to the patient, or the correct drug is incorrectly administered. The name-attribute similarity scores may be generated based on orthographic, phonetic, and / or phonological analysis. The product-attribute similarity scores may be generated based on the drugs'strengths, indications, dosages, administration routes, manufacturers, pharmacological categories, storage requirements, colors, shapes, legal standing, trademark description, and / or other attributes. The composite quantitative comparison may include severity-weighted similarity scores or both similarity scores and severity of confusion scores. The severity of confusion indicators may include a therapeutic index and / or a contraindication index.

A computerized method for evaluating medical reports includes identifying at least one or more medical reports stored in a database related to the medical condition, validating the identified medical reports by determining if key words associated with the medical condition found in the at least one or more reports are surrounded by a negative context and extracting relevant data from the medical reports. The exemplary method also includes evaluating the relevant data from the medical reports with provisions set forth in clinical guidelines corresponding to a medical condition, storing a flag identifying one or more of the medical reports as noncompliant when its corresponding relevant data does not comply with the provisions set forth in the clinical guideline unless a valid contraindication applies and displaying the medical reports identified as noncompliant.

To help consumers around the world reduce the confusion and complexity of choosing among thousands of wellness products that are effective for their particular medical conditions and / or wellness goals, the present inventor, devised one or more exemplary systems, methods, software, and data structures for recommending products, such as health, fitness, and nutritional products, to consumers. One exemplary system receives user profile information, such as gender, age, medical condition(s), wellness goal(s), biometric data, allergies and sensitivities, and / or nutrition information, and recommends products based on the consumer profiles and product ingredient efficacy and / or contraindications for the medical conditions and / or wellness goals. The system recommends the most scientifically effective products for a particular consumer, while accounting for contraindications thereby reducing risk potentially harmful products. The system ultimately empowers consumers around the world to make safer and more knowledgeable decisions regarding their own wellness.

The invention relates to a hospital medication management system with the medication safety monitoring and intervening functions. The hospital medication management system with the medication safety monitoring and intervening functions is composed of a medication safety monitoring system and an early informatization intervening system. The computer database technology and other technologies are adopted for the medication safety monitoring system. According to the professional examination principle in the medicine science and the pharmaceutical science, with the specialized knowledge in the medicine science and the pharmaceutical science as standards, relevant medicine data information can be provided when doctor's advice is entered and examination of drug allergy histories, drug interactions, contraindications, side effects, external injection medicine compatibility and the like is performed on the doctor's advice to assist a doctor in correctly screening medicines and determining the doctor's advice, a prompt and an alarm can be given timely when problems are found, and thus the possibility of errors is reduced.

The invention belongs to the field of a health care product, and relates to gastrointestinal health preserving pulp and a preparation method of the gastrointestinal health preserving pulp. The gastrointestinal health preserving pulp is obtained through the following steps that 5 to 50 weight parts of corn, 5 to 20 weight parts of calcium carbonate or calcium bicarbonate, 5 to 20 weight parts of lupeose and 10 to 80 parts of other five-mixed-grain rice except the corn and edible traditional Chinese medical materials are weighed, the corn, other five-mixed-grain rice and the edible traditional Chinese medical materials are ground into pulp by a bean milk machine after the addition of a proper amount of water, then, the calcium carbonate or calcium bicarbonate and the lupeose are added, and the materials are uniformly mixed. The five-mixed-grain rice and the edible traditional Chinese medical materials are adopted to be compounded according to a specific mixing ratio, the obvious curative effect is realized on improving the gastrointestinal function, the raw material resources are sufficient, all ingredients have no toxic or side effect, and no matching contraindication exists.

Systems, methods, and user interfaces for providing dynamic risk stratification for clinical decision support are provided. Selections of patient types are received for patients. Assessments to utilize are determined in accordance with the patient types. The assessments are displayed to facilitate first clinicians assessing risk factors and contraindications for the patients. Information associated with the patients is received. Second clinicians may be alerted if risk factors for the patients are identified and the assessments have not been completed. Pharmacologic and / or mechanical prophylaxis is recommended and overall risk levels associated with the patients are indicated.

The invention provides a drug recommendation method. The method comprises steps that the natural language processing technology is utilized to construct a drug knowledge map; the medical record structure technology is utilized to construct a patient portrait based on the patient information, drugs that the patient should not take are filtered according to the drug knowledge map, the patient portrait and the preset recommendation algorithm, and a patient-friendly medication regimen is recommended to a patient. The method is advantaged in that problems that the user information obtained throughthe word-matching-based search method is too small and only a relatively large drug candidate list is recommended are solved, the drugs that the patient should not take are filtered according to the patient portrait and the preset recommendation algorithm, the patient can be recommended for the drugs that are more suitable for the patient, and the situation that a recommended drug is just a contraindication to the user is avoided.

The invention provides knowledge graph-based precise-recommendation technology of offline medicine retail. The technology is based on a medicine knowledge graph. The graph mainly includes entities ofdiseases, Chinese and Western medicine, people groups, health products and the like and association relationships among the entities. The association relationships mainly include contraindication relationships, interaction relationships, inclusion relationships, adjoining relationships, assistance relationships, affiliation relationships and the like. A people group set is generated through a people group label generation algorithm based on density clustering, and contains people group category labels and medicine commodities belonging to all the labels; then a target user is labeled accordingto a medicine combination bought by the user; and finally, interest degrees of the user are calculated according to a label, and a recommendation result list is generated. The technology can solve the problems which are of sparseness and single categories of user data and are encountered by medicine retail enterprises in precise recommendation, and the medicine knowledge graph on which the technology is based can also solve the problem of particularity of the medicine commodities and the problem of medicine field knowledge lacking of users. The technology can satisfy most precise-recommendation service demand in an offline medicine retail environment, and has very high market competitiveness and broad application prospects.

Disclosed is a remote controller for an implantable medical device having stored contraindication information, which includes information which a patient or clinician might wish to review when assessing the compatibility of a given therapeutic or diagnostic technique or activity with the patient's implant. The stored contraindication information is available through a display of the remote controller or via a wired, wireless, or portable drive connection with an external device. By storing contraindication information with the implant's remote controller, patient and clinician can more easily determine the safety of a particular therapeutic or diagnostic technique or physical activity with the patient's implant, perhaps without the need to contact the manufacturer's service representative.

Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and / or inducing weight loss in patients in need thereof, particularly in individuals having a contraindication for treatment with biguanide compounds, are provided comprising administering delayed release formulations of such biguanide compounds, including metformin, targeted to the small intestine.

The invention discloses a watch type first aid positioning alarm device based on real-time monitoring of physiological parameters. A physiological parameter monitoring sensor watch is used for converting the physiological parameters into electric signals and sending the electric signals to an information processing and positioning alarm by radio frequency wireless way, wherein the physiological parameter monitoring sensor watch comprises a piezoelectric or piezoresistive micro-nano fiber membrane sensor, a flexible sensitive material preprocessing circuit installed in the watch, a microprocessor with low power consumption, a radio frequency wireless transmission module, an anti-drop switch, a manual watch alarm switch and a wrist band. The alarm device alarms and provides the user position information to first aid center through global positioning and dual-mode mobile communication positioning technology when accidents happen and simultaneously provides the basic information and contraindication information of the patients to the first aiders. The alarm device has the advantages of small volume, light weight and convenience for long-time wearing and conduces to improving the first aid success rate and the first aid efficiency and reducing the secondary injury possibly caused in the rescue process. The alarm device can be used for automatic alarming under the condition that the old solitary people are in danger and manual alarming under emergency.

Methods for improving the gastrointestinal tolerability of biguanide compounds and for treating metabolic disorders and / or inducing weight loss in patients in need thereof, particularly in individuals having a contraindication for treatment with biguanide compounds, are provided comprising administering delayed release formulations of such biguanide compounds, including metformin, targeted to the small intestine.

Disclosed is a remote controller for an implantable medical device having stored contraindication information, which includes information which a patient or clinician might wish to review when assessing the compatibility of a given therapeutic or diagnostic technique or activity with the patient's implant. The stored contraindication information is available through a display of the remote controller or via a wired, wireless, or portable drive connection with an external device. By storing contraindication information with the implant's remote controller, patient and clinician can more easily determine the safety of a particular therapeutic or diagnostic technique or physical activity with the patient's implant, perhaps without the need to contact the manufacturer's service representative.

A system for the capture, management or use of patient medical and prescription data is disclosed. In some illustrative embodiments, the system includes: a computer system including at least one server computer and at least one physician computer in communication with said at least one server over a network, such as the Internet; wherein said at least one server computer includes a database of drug side effects, interactions or contraindications, which are accessible via said at least one physician computer via a graphical user interface.

A personalized health information discovery and presentation system is presented. The system has an input device, a subject-profile module, an information database, an alignment module, a solutions module, an integration engine, a plan module, a graphical user interface, and a processor. The input device allows a user to enter a personalized subject-profile, the subject-profile module receives the subject-profile and converts it into a recognized health profile. The health information database comprises a library of health information, and the alignment module aligns the recognized health profile with relevant health information. The solution's module parses the relevant information into information subsets, and the integration engine integrates the information; identifies conflicting health information, contraindications, or health warnings; creates notifications; and compiles data for presentation to the user. The plan module converts the integrated health information into a personalized health maintenance plan for display in a form selected by the user.

The invention discloses essential oil for cleaning and caring female private parts and a preparation method of the essential oil, aiming at the problems that the existing products are complicated and inconvenient to use, and not obvious in effect and long in treatment cycle, easily cause injuries or secondary infection of the private parts, and have abundant using contraindication, and consumers can have serious problems due to improper use. The essential oil is prepared from the following components in percentage by weight: 10-15% of lavender spike essential oil, 17-22% of palmarosa essential oil, 12-20% of tea tree essential oil, 18-23% of clary sage essential oil, 10-15% of leptospermum scoparium essential oil, 10-15% of eucalyptus essential oil, and 4-9% of thujanol thyme essential oil. By utilizing the characteristics that the plant essential oil has the excellent antibacterial, antiviral, antimicrobic, sterilization and inflammation-diminishing efficacies, the principle that the plant essential oil has the volatility, the characteristic that the plant essential oil with complicated components can not have drug resistance like antibiotics, as well as the characteristic that that the essential oil has more curative effects through scientific mixing, the essential oil provided by the invention has the advantages of obvious effect and rapidness in taking effect.

A polyantiseptic antimicrobial pharmaceutical composition for oral use, for the hygiene and treatment of oral diseases of bacterial, mycotic or viral etiology, for over-the-counter sale, without contraindications. The composition does not contain phenolic or, chlorophenolic compounds, and consists of a mixture of hydrogen peroxide, eugenol, natural camphor, zinc sulphate, sodium fluoride, xylitol, cetylpyridinium chloride and excipients. The formulation is used to deodorise, disinfect, astringe and soothe inflammation of the oral area, avoids the neoformation of bacterial plaque, prevents tooth cavities, inhibits the formation of dental tartar, improves the resistance of teeth to cavities, and treats and prevents oral aphthous ulcers.

Apparatus and associated methods related to determining medical services appropriate to a patient in response to a patient lifecycle event: presenting the medical services to the patient for selection; optionally scheduling the selected medical services; and automatically presenting the selected services for prepayment. The patient lifecycle event may be, for example, a doctor's order, diagnosis, condition change, payment, admission, or discharge. The services presented to the patient may be determined in response to, and as a function of, the lifecycle event. For example, the services presented may include procedures determined after the lifecycle event, in view of patient medical history. In an illustrative example, the services presented may be based on medical indication, contraindication, provider or facility availability, or patient scheduling preference, advantageously permitting more medically relevant, beneficial, convenient, or cost-effective services. Various examples may advantageously provide a discount for a service bundle provided at a particular time or facility or by an affiliated physician or medical group.

Apparatus and associated methods related to determining medical services appropriate to a patient in response to a patient lifecycle event: presenting the medical services to the patient for selection; optionally scheduling the selected medical services; and automatically presenting the selected services for prepayment. The patient lifecycle event may be, for example, a doctor's order, diagnosis, condition change, payment, admission, or discharge. The services presented to the patient may be determined in response to, and as a function of, the lifecycle event. For example, the services presented may include procedures determined after the lifecycle event, in view of patient medical history. In an illustrative example, the services presented may be based on medical indication, contraindication, provider or facility availability, or patient scheduling preference, advantageously permitting more medically relevant, beneficial, convenient, or cost-effective services. Various examples may advantageously provide a discount for a service bundle provided at a particular time or facility or by an affiliated physician or medical group.

The concurrent administration of chemotherapy and immunotherapy has been considered a contraindication because of the concern that the induced lymphopenia would ablate therapeutic efficacy of immunotherapy. Temozolomide has been shown to be an effective chemotherapeutic for patients with malignant gliomas and to deprive patients with glioblastoma (GBM) patients of this agent in order to treat with immunotherapy is controversial. Despite conventional dogma, we demonstrate that both chemotherapy and immunotherapy can be delivered concurrently without negating the effects of immunotherapy, in fact, the temozolomide induced lymphopenia may actually be synergistic with a peptide vaccine.

Ischemia is treated to prevent or manage disease by delivering stem cells derived from cord blood and / or tissue. A patient suffering from disease caused in at least some part by ischemia is selected. At least one dose consisting of an effective amount of stem cells is administrated through intravenous (IV), intra thecal, intra-arterial, via catheter into the organ, via Myostar catheter into the heart, intracoronary, intrapericardial, and / or by direct injection into the organ. Effectiveness of the administration is monitored at selected time periods to determine whether there exists an improved clinical indication. A second dose is administered by a method that is at least invasive as that utilized in the prior dose, and the steps are repeated until the clinical indication shows improvement or until there is contraindication to continued treatment. Diseases include at least one of Ischemia, arteriosclerosis, complications of ischemia, decreased perfusion, aging or diabetes.

The invention relates to a preparation method of high-purity D-glucosamine sulfate, which is characterized by comprising the steps of: dissolving: weighting an alkali material into an organic solvent to prepare an alkali solution; freeing: adding the D-glucosamine sulfate with purity not less than 95 percent into the alkali solution under stirring, reacting to prepare a mixed solution containing chloride crystals and free D-glucosamine; desalting: filtering the mixed solution to remove chloride to obtain an organic solution containing the free D-glucosamine; salifying: dropping sulfuric acid into the organic solution obtaining the free D-glucosamine for reacting to prepare the D-glucosamine sulfate; and refining to obtain the finished product. The method has advanced operating process, simple equipment and less pollution; the used organic solvents can be recycled; and the prepared high-purity D-glucosamine sulfate contain no potassium, sodium or chloride ions, has no use contraindication, and is safe to use.

The invention discloses a remote intelligent medication service system. The system includes an intelligent medical kit, a medication analysis server and a check client; the intelligent medical kit is used for sending medication information and patient work and rest time information to the medication analysis server and reminding a patient to take a medicine according to a final medication scheme returned by the medication analysis server; the medication analysis server is used for generating a preliminary medication scheme for the patient according to the patient medication information and the patient work and rest time information; the check client is used for checking the preliminary medication scheme generated by the medication analysis server through the interaction with the medication analysis server to obtain the final medication scheme for the patient. According to the medication information and the work and rest time information of the patient, the system is used for optimizing and checking the medication scheme of the patient, helping the patient reasonably take the medicine timely according to the quantity, and providing manual medication service for contraindications in drug combination and the conditions that the patient misses the medicine.

The embodiment disclosed by the invention comprises a novel method for providing medical treatment reference information, which comprises the following steps: providing a plurality of alternative items for a user to select and determine a query request at a client computer, obtaining results containing the medical treatment reference information according to the query request and providing the result to the user, wherein the alternative items comprise symptom items. One aspect of the invention relates to the graphical user interface on the computer, and the graphical user interface comprises the alternative items for the user to select and determine the query request so as to provide the medical treatment reference information according to the query request. Provided medical treatment reference information results comprise medical treatment inspection items, hospital registering departments, medical treatment contraindications, pharmaceutical data, traditional Chinese medicine disease names, Western medicine disease names, traditional Chinese medicine medical treatment suggestions, Western medicine medical treatment suggestions, traditional Chinese medicine case records and Western medicine case records.